Impact of the liver environment upon the efficacy of induction therapy

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor

Effective use of ibrutinib in the treatment of ABC lymphoma tumours

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment

Role of genomics in assessing risk, especially in ovarian cancer

The relationship between obesity and cancer, and other dietary factors

New antibody-drug conjugate shows early promise against all forms of melanoma

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib

The global control and prevention of cervical cancer caused by HPV

Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer